POTS and Dysautonomia: What's Really Driving Your Symptoms and How to Actually Recover
If you have spent any time researching POTS or dysautonomia online, you have probably found the same advice repeated everywhere - compression socks, increase your salt, drink more fluids, try to exercise. And yes, those things matter. They are part of the picture.
But if you are reading this, chances are you have already tried those things. You are already wearing the socks. You are already salting your food. You are already pushing through the fatigue to do what the physio told you. And you are still not well.
Here is what I rarely see discussed openly in the POTS and dysautonomia space - the real question is "why did this system break down, and what has been attacking it?"
In my clinical experience, POTS and dysautonomia are almost never one thing. They are the end result of a body that has been under siege from multiple directions, often for a very long time, until the autonomic nervous system.
I find patients with POTS are people whose bodies have been fighting hard against real threats - infections that were never fully cleared, toxic environments they lived or worked in, immune systems that are overwhelmed, hormones that stopped working properly under relentless physiological stress, gut microbiomes that were disrupted.
POTS disproportionately affects women. It frequently emerges after a viral infection. It sits at the intersection of the immune system, the autonomic nervous system, the gut, the hormonal system and the brain. It is one of the most underdiagnosed, mismanaged and misunderstood conditions in modern medicine - not because it is mysterious, but because finding the real drivers requires looking at the whole person, not just the heart rate monitor.
This post is for people who are done with surface-level answers. If you want to understand what is actually happening in your body - and what a real recovery approach looks like - read on.
What Is Dysautonomia and POTS?
The autonomic nervous system (ANS) controls everything your body does automatically — heart rate, blood pressure, breathing, digestion, temperature regulation, pupil dilation, bladder function and the switch between fight-or-flight (sympathetic) and rest-and-digest (parasympathetic) states.
Dysautonomia is a broad term for dysfunction of this system. POTS is one of the most common forms.
POTS is defined by an abnormal increase in heart rate upon standing — in adults, a rise of more than 30 beats per minute within 10 minutes of standing, without a significant drop in blood pressure. In children the threshold is higher. This happens because the autonomic system fails to adequately constrict blood vessels in the lower body when you stand, causing blood to pool, the heart to race to compensate, and a cascade of symptoms to follow.
Common symptoms include:
Heart pounding or racing upon standing or minimal exertion
Dizziness and lightheadedness, especially on standing
Profound fatigue that does not improve with rest
Brain fog, cognitive difficulties and memory problems
Language and word-finding difficulties
Near-fainting or fainting episodes
Nausea and gut dysfunction
Temperature dysregulation
Anxiety and panic-like symptoms
Salt and fluid cravings
Exercise intolerance
Sleep disturbances
Visual disturbances
What makes POTS particularly complex is that it is rarely a standalone condition. It is almost always secondary to underlying drivers — and identifying and addressing those drivers is what separates temporary symptom management from genuine recovery.
Who Gets POTS and Why
The epidemiology of POTS tells us something important about its nature:
Predominantly affects females — approximately 80% of POTS patients are women, pointing strongly to hormonal, immune and autonomic sex differences as relevant mechanisms
Frequently triggered by infections — viral infections are the most commonly reported trigger, including Epstein-Barr Virus (EBV), COVID-19, Lyme disease and other chronic infections. Post-viral POTS has become dramatically more prevalent since 2020.
Often emerges in adolescence and young adulthood — a period of significant hormonal change and immune system development
Associated with other conditions — hypermobile Ehlers-Danlos Syndrome (hEDS), mast cell activation syndrome (MCAS), autoimmune conditions and a history of concussion or head trauma
The pattern is clear: POTS is most often the downstream consequence of a system under significant cumulative stress - viral, toxic, hormonal, structural or emotional. Understanding which stressors are driving an individual's presentation is the foundation of effective treatment.
The Core Subtypes: Different Drivers, Different Approaches
POTS is not one condition. There are distinct physiological subtypes, and each requires a nuanced approach:
Hypovolaemic POTS
The most common subtype. Characterised by genuinely low blood volume — the body simply does not have enough circulating fluid to adequately perfuse the brain and upper body on standing.
Drivers include chronic dehydration, low aldosterone, adrenal dysfunction and inadequate salt and mineral intake. The body is blood-volume depleted and the heart races trying to compensate.
Hyperadrenergic POTS
Characterised by excessively high norepinephrine levels upon standing. These patients often experience more pronounced anxiety, tremor, hypertension and palpitations rather than low blood pressure.
The norepinephrine excess is frequently driven by underlying infections (EBV, Lyme, parasites), mast cell activation (histamine triggers norepinephrine release), blood sugar dysregulation and chronic HPA axis dysfunction.
Neuropathic POTS
Involves damage to the small nerve fibres that control blood vessel constriction in the lower limbs. Without adequate nerve signalling, vessels fail to constrict on standing and blood pools.
Small fibre neuropathy can result from autoimmune attack, viral damage, metabolic dysfunction and chronic inflammation.
The Deeper Drivers: What Is Actually Breaking the System?
This is where the clinical picture gets more complex — and more treatable. In practice, POTS presentations cluster around a set of recurring underlying drivers:
1. Chronic Infections
EBV, COVID-19, Lyme disease and its co-infections, and various parasitic infections are among the most common infectious triggers. These pathogens do several things simultaneously:
Drive a Th2-skewed immune response that impairs the body's ability to fight further infections
Trigger autoimmune responses against autonomic nerve tissue
Directly stimulate mast cell activation and histamine release
Create chronic neuroinflammation affecting the autonomic nervous system
Dysregulate the HPA axis through prolonged immune activation
2. Mast Cell Activation Syndrome (MCAS)
MCAS and POTS have an extraordinarily high co-occurrence rate. Mast cells, when chronically activated by infections, mould, food antigens or chemical triggers, release histamine and other mediators that:
Cause inappropriate vasodilation contributing to blood pooling
Trigger norepinephrine and epinephrine release as the body attempts to counter the vasodilation
Drive oestrogen dominance (histamine stimulates oestrogen release and oestrogen in turn stimulates histamine release — a reinforcing cycle)
Create chronic low-grade inflammation throughout the autonomic nervous system
Contribute to the food reactivity, gut dysfunction and skin symptoms many POTS patients experience
Mould exposure is a particularly significant and underrecognised mast cell trigger. Mycotoxins directly activate mast cells, suppress the immune system's ability to clear the ongoing trigger, and drive the Th2 immune skewing that prevents recovery. Patients who have lived in water-damaged buildings often have the most treatment-resistant presentations until the mould piece is properly addressed.
3. HPA Axis Dysfunction and Adrenal Insufficiency
The hypothalamic-pituitary-adrenal (HPA) axis is the master stress response system. In chronic POTS, this axis is almost universally dysregulated.
The cascade typically looks like this:
Chronic stressor (infection, mould, food reactivity, emotional trauma) leading to histamine release and norepinephrine secretion to counteract histamin. Then cortisol secretion follows norepinephrine AND over time, cortisol receptor resistance develops. Eventually cortisol output itself declines and causes HPA insufficiency.
Low cortisol is profoundly destabilising for the autonomic nervous system. Cortisol helps maintain blood vessel tone, regulate blood sugar, modulate immune responses and support sodium retention. Without adequate cortisol, the entire system becomes more reactive and less resilient.
The clinical question is always: what is perpetuating the stress signal that is breaking the HPA axis? Identifying and removing that driver - whether infection, mould, food sensitivity, structural compression or emotional trauma - is more important than simply supporting the adrenals in isolation.
4. Food Sensitivities and Histamine Load
Gluten, dairy, eggs, nightshades, caffeine and high-histamine foods are the most common dietary drivers in POTS. Each of these can:
Trigger histamine release through immune or mast cell mechanisms
Stimulate the epinephrine response as the body counters histamine
Drive C1/atlas vertebral subluxation through inflammatory mechanisms (the atlas is directly connected to the brainstem and the rest-and-digest circuitry)
Perpetuate the cortisol-norepinephrine-adrenal cycle
Caffeine warrants special mention - it directly stimulates cortisol and norepinephrine release, worsens adrenal burden, disrupts sleep architecture and dehydrates. For POTS patients it is not a lifestyle preference to eliminate - it is a clinical necessity.
5. Structural and Craniocervical Factors
The C1 (atlas) vertebra sits at the junction of the brainstem and spinal cord and directly interfaces with the vagus nerve - the primary nerve of the parasympathetic rest-and-digest system. C1 subluxation or craniocervical instability can:
Compress the brainstem affecting autonomic regulation
Impair vagal tone contributing to sympathetic dominance
Be triggered or perpetuated by inflammation from food sensitivities
Create a feedback loop where structural compression worsens autonomic dysfunction which worsens inflammation which worsens structural instability
6. Methylation Dysfunction
Methylation is the biochemical process by which the body regulates neurotransmitter metabolism, amongst many other functions. In POTS, two methylation enzymes are particularly relevant:
PNMT - converts norepinephrine to epinephrine. Impaired PNMT means norepinephrine accumulates, driving the hyperadrenergic picture.
COMT - breaks down catecholamines including norepinephrine and epinephrine. COMT variants (common in POTS patients) slow this breakdown, perpetuating the high norepinephrine state.
SULT - sulphation pathway involved in oestrogen metabolism and neurotransmitter regulation. Impaired SULT contributes to oestrogen dominance and histamine excess.
Supporting methylation through targeted B vitaminsm, minerals and specific botanical support addresses a fundamental biochemical driver rather than just symptoms.
7. Hormonal Dysregulation
The oestrogen-histamine relationship is one of the most important and least discussed aspects of POTS in women:
Oestrogen stimulates histamine release from mast cells
Histamine stimulates further oestrogen production from the ovaries
This creates a reinforcing cycle driving mast cell activation, autonomic instability and HPA dysregulation
Progesterone counterbalances this effect - progesterone deficiency or oestrogen dominance amplifies the entire picture
Hormonal dysregulation in POTS is not a primary problem to treat with hormone therapy — it is a downstream consequence of histamine excess, adrenal dysfunction and chronic stress that resolves as the underlying drivers are addressed.
8. Vitamin D Receptor Dysfunction
Low vitamin D and/or impaired vitamin D receptor function is associated with orthostatic intolerance. Vitamin D is a critical immune regulator, and its deficiency allows the inflammatory and autoimmune drivers of POTS to continue unchecked. It also directly affects magnesium metabolism - and magnesium deficiency is near-universal in POTS patients.
9. EMF and Environmental Factors
Emerging research and substantial clinical observation suggests that electromagnetic field (EMF) exposure can worsen mast cell activation and autonomic nervous system reactivity in sensitive individuals. For patients with significant MCAS and hyperadrenergic presentations, reducing EMF burden and incorporating grounding practices can be a meaningful part of the overall protocol.
The Recovery Reality: What to Expect
POTS recovery is not linear and it is not fast. Understanding this prevents the discouragement that derails many patients.
System crashes are normal. The autonomic nervous system has been operating in a pathological pattern for months or years. As healing occurs, the system periodically destabilises before restabilising at a higher level of function. This is not a sign that treatment is failing — it is a sign that the system is reorganising.
Stressor identification is ongoing. As one layer of dysfunction resolves, the next layer often becomes visible. A patient who addresses their mould burden may then find their viral load becomes more apparent. This is progress, not regression.
The timeline is measured in months. Meaningful adrenal recovery requires a minimum of 6 months of consistent support. Microbiome restoration takes 8–12 weeks minimum. Nerve fibre regeneration in neuropathic POTS can take 12–24 months. Expecting resolution in weeks sets up inevitable disappointment.
Key Takeaways
POTS and dysautonomia are not anxiety disorders, psychosomatic conditions or lifestyle problems - they are complex dysregulations of the autonomic nervous system with identifiable, treatable root causes
The most common drivers are chronic infections (EBV, COVID, Lyme), mould and mycotoxin exposure, mast cell activation, HPA axis dysfunction, methylation impairment, food sensitivities and structural craniocervical factors - often in combination
The three pillars of immediate support are hydration with adequate salt and minerals, blood volume building, and nervous system regulation
Injectable methylcobalamin B12, targeted adaptogens, compression garments, atlas correction and vagal nerve practices are amongst the most impactful interventions in clinical practice
Recovery is possible but requires a systematic, patient, multi-system approach that addresses root causes rather than managing symptoms in isolation
The emotional and psychological dimension of recovery is inseparable from the physiological
You Do Not Have to Figure This Out Alone
POTS and dysautonomia are complex. The intersection of infection, immune dysfunction, gut health, hormones, structural mechanics, methylation and the nervous system requires clinical experience to navigate - not another Google rabbit hole at midnight.
At Bio-Detective Studios, we take a comprehensive root-cause approach to POTS and dysautonomia. We use functional testing to identify your specific drivers, build a layered and individualised recovery protocol, and walk alongside you through a recovery process that actually addresses why your system broke down - not just what to do about the symptoms.
If you recognise your story in this post, we would love to help you find your way forward.
📞 Book your initial consultation with Bio-Detective Studios Today
This blog post is written for educational purposes and does not constitute medical advice. Always work with a qualified healthcare practitioner for diagnosis and individualised treatment of POTS and dysautonomia